SHARE
Nephropathic Cystinosis Treatment Market

Nephropathic Cystinosis Treatment - Global Market Outlook (2019 -2027)

4.3 (35 reviews)
Published: November 2020 ID: SMRC20100
4.3 (35 reviews)
Published: November 2020 ID: SMRC20100

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Nephropathic Cystinosis Treatment Market is accounted for $215.00 million in 2019 and is expected to reach $270.25 million by 2027 growing at a CAGR of 2.9% during the forecast period. Emergence of patient assistance, helping hand programs for nephropathic cystinosis patients and rise in awareness regarding nephropathic cystinosis among people through various programs are the major factors propelling the market growth. However, lack of healthcare professionals is hampering the market growth.

Slide31_400x200.png

Nephropathic cystinosis is a rare form of disease. It is an inherited (autosomal recessive) lysosomal storage disorder caused by defective transport of the amino acid cystine out of lysosomes. The stored cystine is poorly soluble and crystallizes within the lysosomes of many cell types, leading to widespread tissue and organ damage. Nephropathic cystinosis treatment comprises cysteamine depletion therapy with symptomatic treatment for the disease. At a severe stage, renal transplantation option is adopted.

Based on the treatment type, the therapy segment is going to have a lucrative growth during the forecast period due to the factors such as better efficacy to cure symptoms, delayed renal transplantation, and novel therapy approaches being developed in recent times. The therapy segment is further sub-segmented into systemic depletion therapy and symptomatic therapy. Systemic depletion therapy is a more popular therapy due to being the only effective treatment option for nephropathic cystinosis.

By geography, North America is going to have a lucrative growth during the forecast period due owing to comparatively higher diagnosed patient population for nephropathic cystinosis in the region, availability of U.S. FDA approved products, and research funding for new treatment approaches. For instance, as per Cystinosis Research Network (CRN), cystinosis affects an estimated 2,000 people worldwide with just over 600 of those diagnosed living in the U.S.

Some of the key players profiled in the Nephropathic Cystinosis Treatment Market include AVROBIO, Inc, Chiesi Farmaceutici S.p.A, Eloxx Pharmaceuticals, GlaxoSmithKline plc, Horizon Therapeutics, Leadiant Biosciences, Inc, Mylan, and Recordati Rare Diseases.

Treatment Types Covered:
• Renal Transplantation
• Therapy

Applications Covered:
• Ambulatory Surgical Centres
• Clinics
• Hospitals
• Specialty/Retail Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary          
            
2 Preface       
    
 2.1 Abstract          
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology        
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources       
  2.5.2 Secondary Research Sources       
  2.5.3 Assumptions        
            
3 Market Trend Analysis         
 3.1 Introduction         
 3.2 Drivers          
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats          
 3.6 Application Analysis        
 3.7 Emerging Markets         
 3.8 Impact of Covid-19         
            
4 Porters Five Force Analysis         
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes        
 4.4 Threat of new entrants        
 4.5 Competitive rivalry         
            
5 Global Nephropathic Cystinosis Treatment Market, By Treatment Type     
 5.1 Introduction         
 5.2 Renal Transplantation        
 5.3 Therapy          
  5.3.1 Cysteine Depleting Therapy       
  5.3.2 Symptomatic Therapy       
  5.3.3 Systemic Depletion Therapy       
            
6 Global Nephropathic Cystinosis Treatment Market, By Application     
 6.1 Introduction         
 6.2 Ambulatory Surgical Centres        
 6.3 Clinics          
 6.4 Hospitals          
 6.5 Specialty/Retail Pharmacies        
            
7 Global Nephropathic Cystinosis Treatment Market, By Geography     
 7.1 Introduction         
 7.2 North America         
  7.2.1 US         
  7.2.2 Canada         
  7.2.3 Mexico         
 7.3 Europe          
  7.3.1 Germany         
  7.3.2 UK         
  7.3.3 Italy         
  7.3.4 France          
  7.3.5 Spain         
  7.3.6 Rest of Europe        
 7.4 Asia Pacific         
  7.4.1 Japan         
  7.4.2 China         
  7.4.3 India         
  7.4.4 Australia         
  7.4.5 New Zealand        
  7.4.6 South Korea        
  7.4.7 Rest of Asia Pacific        
 7.5 South America         
  7.5.1 Argentina        
  7.5.2 Brazil         
  7.5.3 Chile         
  7.5.4 Rest of South America       
 7.6 Middle East & Africa        
  7.6.1 Saudi Arabia        
  7.6.2 UAE          
  7.6.3 Qatar         
  7.6.4 South Africa        
  7.6.5 Rest of Middle East & Africa       
            
8 Key Developments          
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 8.2 Acquisitions & Mergers         
 8.3 New Product Launch        
 8.4 Expansions         
 8.5 Other Key Strategies        
            
9 Company Profiling          
 9.1 AVROBIO, Inc         
 9.2 Chiesi Farmaceutici S.p.A             
 9.3 Eloxx Pharmaceuticals              
 9.4 GlaxoSmithKline plc              
 9.5 Horizon Therapeutics              
 9.6 Leadiant Biosciences, Inc              
 9.7 Mylan                
 9.8 Recordati Rare Diseases              


List of Tables           
1 Global Nephropathic Cystinosis Treatment Market Outlook, By Region (2018-2027) ($MN)   
2 Global Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)  
3 Global Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN) 
4 Global Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)   
5 Global Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN) 
6 Global Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN) 
7 Global Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN) 
8 Global Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)  
9 Global Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN) 
10 Global Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)   
11 Global Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)   
12 Global Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN) 
13 North America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)  
14 North America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN) 
15 North America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
16 North America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN) 
17 North America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN) 
18 North America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
19 North America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)  
20 North America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)  
21 North America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
22 North America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)  
23 North America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)  
24 North America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
25 Europe Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)   
26 Europe Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)  
27 Europe Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN) 
28 Europe Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN) 
29 Europe Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN) 
30 Europe Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN) 
31 Europe Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)   
32 Europe Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)  
33 Europe Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN) 
34 Europe Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)   
35 Europe Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)   
36 Europe Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN) 
37 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)  
38 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)  
39 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
40 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN) 
41 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN) 
42 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
43 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)  
44 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)  
45 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
46 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)   
47 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)  
48 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
49 South America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)  
50 South America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN) 
51 South America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
52 South America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN) 
53 South America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN) 
54 South America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
55 South America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)  
56 South America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)  
57 South America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
58 South America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)  
59 South America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)  
60 South America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
61 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)  
62 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN) 
63 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
64 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
65 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
66 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
67 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN) 
68 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN) 
69 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
70 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)   
71 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN) 
72 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials